Article
Inhibition of proliferation-linked signaling cascades with atractylenolide I reduces myofibroblastic phenotype and renal fibrosis.
Biochemical pharmacology - 1 Jan 2021
Guo Yangyang, Xiao Yanyi, Zhu Hengyue, Guo Hangcheng, Zhou Ying, Shentu Yangping, Zheng Chenfei, Chen Chaosheng, Bai Yongheng
Abstract excerpt
Renal fibrosis is a frequent axis contributing to the occurrence of end-stage nephropathy. Previously, it has been reported that atractylenolide Ⅰ (ATL-1), a natural compound extracted from Atractylodes macrocephala, has anti-cancer and antioxidant effects. However, the renal anti-fibrotic effects of action remain unclear. In this study, the anti-fibrotic effects of ATL-1 were examined in fibroblasts, tubular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
